Skip to main content

Table 3 Distribution of cases and controls among the high or low level categories of the hemostatic parameters

From: Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCRgenes are associated with breast cancer: a case-control study

Hemostatic parameter

Cases (n)

Controls (n)

OR

95% CI

P-value

Coagulation activity:

ETP (%)*

<90th percentile

309

246

Ref.

Ref.

Ref.

>90th percentile

37

27

1.09

0.65-1.84

0.744

Lag time (%)*

>10th percentile

211

246

Ref.

Ref.

Ref.

<10th percentile

135

27

5.83

3.71-9.16

<0.001

ttPeak (%)*

>10th percentile

206

249

Ref.

Ref.

Ref.

<10th percentile

140

24

7.05

4.40-11.29

<0.001

Peak (%)*

<90th percentile

208

246

Ref.

Ref.

Ref.

>90thpercentile

138

27

6.05

3.85-9.50

<0.001

APC resistance (nAPC-sr)

FV Leiden non-carriers

<90th percentile

190

228

Ref.

Ref.

Ref.

>90th percentile

135

25

6.48

4.06-10.35

<0.001

FV Leiden carriers

<90th percentile

4

18

Ref.

Ref.

Ref.

>90th percentile

17

2

38.3

6.2-236.6

<0.001

D-dimer (ng/mL)

<90th percentile

292

246

Ref.

Ref.

Ref.

>90th percentile

65

27

2.03

1.26-3.28

0.004

Coagulation inhibitors:

     

AT (%)

>10th percentile

215

246

Ref.

Ref.

Ref.

<10th percentile

135

27

5.72

3.64-8.99

<0.001

Protein C (%)

>10th percentile

310

246

Ref.

Ref.

Ref.

<10th percentile

40

27

1.18

0.702-1.97

0.539

Protein S (%)

>10th percentile

325

246

Ref.

Ref.

Ref.

<10th percentile

22

27

0.62

0.34-1.11

0.106

Free TFPI (ng/mL)

>10th percentile

319

246

Ref.

Ref.

Ref.

<10th percentile

39

27

1.11

0.66-1.87

0.683

  1. ORs, 95% CI and P-values were obtained by logistic regression with respect to cases.
  2. AT = antithrombin. ttpETP = time to thrombin peak. nAPC-sr = normalised APC sensitivity ratio. (%) describes activity as compared to pooled normal plasma (PNP). *CAT-assay variables.